MELI
MercadoLibre, Inc.
MELI has the edge over TSLA overall, supported by stronger valuation and stronger modeled upside.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
MELI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Stable |
MELI's revenue and cash flow are currently strong, and its profitability and balance sheet are stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
MELI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $1,475 | — |
| Current | 40x | $1,475 | — |
| Cheap | 50x | $1,874 | +27% |
| Fair | 75x | $2,798 | +90% |
| Expensive | 193x | $7,183 | +387% |
Historical ranges are pointers, not guarantees.
MELI has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
MELI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MELI, but weaker profitability.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
TSLA has the edge over MELI on the outlook, with more favorable profitability expectations.
MELI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $44.82 | +20% |
| Q3 2026 | $37.28 | -9% |
| Q2 2026 | $36.77 | -9.2% |
| Q1 2026 | $37.89 | -6.8% |
| Q4 2025 | $39.40 | +4.5% |
| Q3 2025 | $40.97 | +45% |
| Q2 2025 | $40.48 | +46% |
| Q1 2025 | $40.65 | +82% |
| Q4 2024 | $37.69 | +93% |
MELI has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
MELI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $10.8B | +45% |
| Q2 2026 | $10.2B | +50% |
| Q1 2026 | $8.8B | +49% |
| Q4 2025 | $8.8B | +45% |
| Q3 2025 | $7.4B | +39% |
| Q2 2025 | $6.8B | +34% |
| Q1 2025 | $5.9B | +37% |
| Q4 2024 | $6.1B | +42% |
MELI has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | -3.5 points |
| Q2 2026 | 6.7% | -5.4 points |
| Q1 2026 | 6.9% | -5.9 points |
| Q4 2025 | 10% | -3.4 points |
| Q3 2025 | 9.8% | -0.7 points |
| Q2 2025 | 12% | -2.2 points |
| Q1 2025 | 13% | +0.7 points |
| Q4 2024 | 14% | +7.9 points |
MELI has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
MELI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $2.4B | -6% |
| Q2 2026 | $3.2B | +22% |
| Q1 2026 | $1.8B | +138% |
| Q4 2025 | $4.8B | +83% |
| Q3 2025 | $2.6B | +89% |
| Q2 2025 | $2.6B | +55% |
| Q1 2025 | $759M | -44% |
| Q4 2024 | $2.6B | +50% |
MELI has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
MELI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -195 shares |
| 1 year | 0% | -178 shares |
| 3 years | +1% | +488K shares |
| 5 years | +2.2% | +1.1M shares |
| Available history | +2% | +987K shares |
MELI has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $1M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $1M |
| Q1 2024 | — |
| Q4 2023 | — |
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
MELI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.3x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 1.0x | Very low |
MELI's net debt is about 2.3 years of its operating earnings (EBITDA), up from 1.4 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over MELI on leverage, with a lower net debt burden relative to earnings.
MELI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.0 | Neutral |
| Stochastic | 6.5 | Oversold |
MELI's weekly RSI is 35 (neutral) and its Stochastic is 6 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
MELI PE vs Consumer Cyclical Sector
| Metric | MELI | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 18x | 120% above |
| PE % | 0 | 47 | 47 pts below |
MELI has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
MELI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,699.1 | 13% below |
| 20 week MA | $1,796.0 | 18% below |
| 50 week MA | $1,820.0 | 19% below |
| 100 week MA | $2,010.5 | 27% below |
| 200 week MA | $1,769.5 | 17% below |
MELI is in a downtrend: it's below all five of its weekly moving averages, and 17% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over MELI on trend strength, trading above more of its moving averages.
MELI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $599.2 | $1,690.5 | +182% |
| 2021 | $1,690.5 | $1,262.7 | -25% |
| 2022 | $1,262.7 | $878.3 | -30% |
| 2023 | $878.3 | $1,571.5 | +79% |
| 2024 | $1,571.5 | $1,725.5 | +9.8% |
| 2025 | $1,725.5 | $2,005.7 | +16% |
| 2026 YTD | $2,005.7 | $1,475.1 | -26% |
MELI has finished higher in four of the last six years, two of them by more than 50%. It's down 26% so far in 2026.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA has the edge over MELI on returns for 2026, with the stronger performance.